Tag: Paragon BioTeck, Inc.
-
Paragon Gives Announces Call for 2020 Koch Kellan Scholarship Applicants
PORTLAND, Ore. — Paragon Gives, a Paragon BioTeck, Inc. initiative, is excited to announce a call for applications for the 2020 Koch Kellan Scholarship worth $10,000. This annual scholarship is awarded to one (1) outstanding graduate medical student committed to pursuing a clinical, teaching or research career in ophthalmology.
-
Alejandro Arboleda Named 2018 Koch Kellan Scholar
PORTLAND, Ore. — Paragon BioTeck, Inc., an ophthalmic pharmaceutical and medical device company, announced today that Alejandro Arboleda has been named its 2018 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to elevating the standard of eye care through social responsibility and…
-
Paragon BioTeck Calls Emerging Leaders to Apply for 2018 Ophthalmology Scholarship
PORTLAND, Ore. — Paragon BioTeck, Inc., a privately-held pharmaceutical and medical device company, today announced the call for the next Koch Kellan Scholar. The annual Koch Kellan Scholarship honors one outstanding graduate medical student committed to elevating the standard of eye care through social responsibility and a clinical, teaching, or research career in ophthalmology. A…
-
Xinxin Zhang Named 2017 Koch Kellan Scholar
PORTLAND, Ore. — Paragon BioTeck, Inc., an ophthalmic pharmaceutical and device company, announced today that Xinxin Zhang has been named its 2017 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to pursuing a clinical, teaching or research career in ophthalmology.
-
Ruling Affirms Patent Claim for Paragon BioTeck’s R-Phenylephrine Hydrochloride Formulation
PORTLAND, Ore., — Paragon BioTeck, Inc., announces a monumental ruling handed down by the United States Patent and Trademark Office (USPTO) affirming claims made by Paragon in the patent for its R-phenylephrine hydrochloride formulation. Paragon is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and…